1 / 90
文档名称:

SCI论文的撰写和投稿注意事项PPT.ppt

格式:ppt   大小:2,464KB   页数:90页
下载后只包含 1 个 PPT 格式的文档,没有任何的图纸或源代码,查看文件列表

如果您已付费下载过本站文档,您可以点这里二次下载

分享

预览

SCI论文的撰写和投稿注意事项PPT.ppt

上传人:yixingmaob 2017/12/7 文件大小:2.41 MB

下载得到文件列表

SCI论文的撰写和投稿注意事项PPT.ppt

相关文档

文档介绍

文档介绍:SCI论文的撰写和投稿注意事项
中华医学杂志英文版
论文的文题
作用
反映论文的主题或主要信息
吸引读者
论文的文题
要求
一般不超过100个字母
排版后不超过2行
可以不是完整的句子
最好反映文章的特色,如:若是随机对照试验,文题需要体现
最好反映研究对象,如动物种类等
论文的文题
论文的摘要
200-300字
一般为四要素结构式,包括Objective (Background), Methods, Results, Conclusion
JAMA分Context, Objective, Design and setting, Patients, Interventions, Main e measures, Results, Conclusions
论文的摘要
目的(背景)
Background Eltrombopag is a new, orally active thrombopoietin-receptor agonist that stimulates thrombopoiesis. We evaluated its ability to increase platelet counts and facilitate treatment for hepatitis C virus (HCV) infection in patients with thrombocytopenia associated with HCV-related cirrhosis.
论文的摘要
方法
Methods Seventy-four patients with HCV-related cirrhosis and platelet counts of 20,000 to less than 70,000 per cubic millimeter were randomly assigned to receive eltrombopag (30, 50, or 75 mg daily) or placebo daily for 4 weeks. The primary end point was a platelet count of 100,000 per cubic millimeter or more at week 4. Peginterferon and ribavirin could then be initiated, with continuation of eltrombopag or placebo for 12 additional weeks.